Le Lézard
Classified in: Health
Subjects: NPT, SVY, PET, ANW

New ASPCA Report Shows USDA Failed to Act in Response to 90 Percent of Animal Welfare Violations in FY23


Despite documenting over 1,000 violations of the Animal Welfare Act at more than 400 commercial dog dealers alone, the USDA only took action against four dog dealers

WASHINGTON, March 15, 2024 /PRNewswire/ -- The ASPCA® (The American Society for the Prevention of Cruelty to Animals®) has released a new report analyzing the U.S. Department of Agriculture's (USDA) inspections of Animal Welfare Act licensed facilities, documented violations, and enforcement actions against violators for the 2023 fiscal year. Based on the ASPCA's analysis of USDA data, federal inspectors documented over 1,000 violations for commercial dog dealers at more than 400 facilities. However, the agency only took action against four dog dealers. Additionally, violation history had no impact on a facility's ability to have their license renewed by the USDA, so all dog dealers who wanted to be relicensed were, even problematic dealers with consistent violations.

"The Animal Welfare Act sets minimal welfare requirements for animals in commercial facilities, including dogs in puppy mills, yet the USDA has continually failed to enforce those requirements," said Robert Hensley, Senior Counsel, ASPCA Legal Advocacy and Investigations. "Thousands of vulnerable dogs and other animals have suffered and died because of the USDA's repeated failure to take any meaningful inaction against problematic dealers, and hundreds more remain at risk under the agency's failing oversight. We urge Congress to step in to fix the USDA's broken system and ensure animals in federally licensed facilities get the protections they deserve."

There are a quarter of a million dogs in USDA licensed commercial breeding facilities, and countless examples of facilities where dogs were suffering, yet the USDA took no action at all. Examples of the USDA's failure to act during FY23, include:

To address these ongoing failures, the ASPCA is urging Congress to include Goldie's Act in the upcoming Farm Bill. Sponsored by a bipartisan team of lawmakers including U.S. Reps. Nicole Malliotakis (R-N.Y.), Mike Quigley (D-Ill.), Brian Fitzpatrick (R-Pa.), Raja Krishnamoorthi (D-Ill.), Chris Smith (R-N.J.), and Zach Nunn (R-IA), Goldie's Act (H.R. 1788) ? which is named after a Golden Retriever who suffered and died in an Iowa puppy mill ? will require the USDA to conduct more thorough inspections, impose penalties for violations, and report suspected cruelty to local law enforcement. The bipartisan Problem Solvers Caucus recently endorsed Goldie's Act, which has garnered support from nearly 150 animal welfare, law enforcement and shelter organizations, and received attention during Secretary Tom Vilsack's recent appearance before the U.S. House Agriculture Committee, when Congressman Nunn raised the urgent need to pass this bill.

For more information or to read the ASPCA's full analysis of the USDA's FY23 enforcement data, please visit www.aspca.org/USDAEnforcement2023.

About the ASPCA®
Founded in 1866, the ASPCA® (The American Society for the Prevention of Cruelty to Animals®) was the first animal welfare organization to be established in North America and today serves as the nation's leading voice for vulnerable and victimized animals. As a 501(c)(3) not-for-profit corporation with more than two million supporters nationwide, the ASPCA is committed to preventing cruelty to dogs, cats, equines, and farm animals throughout the United States. The ASPCA assists animals in need through on-the-ground disaster and cruelty interventions, behavioral rehabilitation, animal placement, legal and legislative advocacy, and the advancement of the sheltering and veterinary community through research, training, and resources. For more information, visit www.ASPCA.org, and follow the ASPCA on Facebook, X, Instagram, and TikTok.

SOURCE ASPCA


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: